Stocktoria

CARLSMED, INC. CARL

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-07-23 · LEI

CARLSMED, INC. statistics & valuation

Market cap$319.7M
P / S6.3×
P / B3.2×
Net margin-58.7%
Return on equity-30.0%
FCF margin-58.6%
Net cash$70.4M
Enterprise value USD$249.2M
Earnings yield EBIT/EV-12.3%
Return on capital-26.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-89.30% -58.70% 20242025
Gross margin (%)
73.80% 75.30% 20242025
Operating margin (%)
-88.80% -60.50% 20242025
Return on equity (%)
-30.00% 20242025
Shares outstanding
4.1M 26.6M 20242025
Net debt ($)
-$24.7M -$70.4M 20242025
Share buybacks ($)
20242025
Return on assets (%)
-46.80% -22.80% 20242025
Free cash flow margin (%)
-94.40% -58.60% 20242025
Debt / equity (×)
0.16× 20242025
EPS ($)
-$6.11 -$2.12 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Gross margin75.3%73.8%
Operating margin-60.5%-88.8%
Net margin-58.7%-89.3%
FCF margin-58.6%-94.4%
Return on assets-22.8%-46.8%
Return on equity-30.0%34.3%
Debt / equity0.16×-0.22×
Current ratio8.875.60

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.